Saladaga, Roselyn M.
HRN: 10-15-46 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/31/2022
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
10/31/2022
11/10/2022
IV
4.5g
Q6h
Hypoxic Enceph
Waiting Final Action
Indication: Empiric Type of Infection: BloodstreamCentral Nervous System Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes